Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ThromboSol to be studied in chemotherapy recipients at M.D. Anderson

Aug. 2, 1999

U.S. patent provides protection for Cyclacel's Penetratin drug delivery technology

Aug. 2, 1999

Nexell and Baxter complete transfer agreements

July 30, 1999

Elan and Merck establish second technology transfer and license agreement

July 28, 1999

Phase I trial results reported for MSI pulmonary delivery of morphine

July 27, 1999

Kurtoxin-1 available for licensing from NIH

July 26, 1999

Cerep and Bristol-Myers Squibb announce collaborative agreements

July 22, 1999

Archaeosomes with or without coenzyme Q10: biodistribution in mice after i.v., i.p. and p.o. dosing

July 21, 1999

Novalon and Ares-Serono enter research collaboration

July 21, 1999

ProNeura completes proof-of-concept studies for sustained drug delivery system

July 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...